MGC Pharmaceuticals are Headline Sponsors of Cannabis Europa London.
MGC Pharmaceuticals Ltd (MXC ASX/LSE) is a European based bio-pharma company supplying GMP plant based and Phytocannabinoid derived products to patients through several distribution channels, with products registered in UK, Ireland, Australia and Brazil. With a robust clinical pipeline directed towards Central Market Authorization for medicines designed for various indications, focused on neurological, autoimmune and oncology.
Employing its ‘Nature to Medicine’ strategy, MGC Pharma has partnered with renowned institutions and academia to optimise cultivation and the development of targeted phytocannabinoid derived medicines products prior to production in the Company’s EU-GMP Certified manufacturing facility.
Last year MGC became the first medicinal cannabis company to be admitted to the main market of the London Stock Exchange.
“As always, MGC is happy to be lead sponsor of such a significant and impactful event…Cannabis Europa provides opportunities for exposure, education, interfacing with the rest of the industry, and gives a real time view into one of the fastest growing and most compelling sectors in today’s market…” – Roby Zomer, Managing Director and CEO
We’re thrilled to be supported by MGC Pharmaceuticals as we work to push the European cannabis industry forward.
You can see more from MGC Pharmaceuticals here.
There are still tickets available Cannabis Europa London on 28-29 June. Get yours now.
